MyAverix Finance
HK · Healthcare
Shandong Xinhua Pharmaceutical Co Ltd (0719)
Drug Manufacturers - Specialty & Generic
Shandong Xinhua Pharmaceutical Co Ltd (0719) is listed on HK in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-05-21, reported market cap is $4.34B, P/E ratio is 13.84, net margin is 3.0%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 0719
Shandong Xinhua Pharmaceutical Co Ltd (0719) — FAQ
What is Shandong Xinhua Pharmaceutical Co Ltd's market cap?
Shandong Xinhua Pharmaceutical Co Ltd (0719) has a reported market cap of $4.34B (data as of 2026-05-21).
What is 0719's P/E ratio?
The price-to-earnings (P/E) ratio for Shandong Xinhua Pharmaceutical Co Ltd (0719) is 13.84 (data as of 2026-05-21).
Does Shandong Xinhua Pharmaceutical Co Ltd pay a dividend?
Dividend yield is not available in the current snapshot for Shandong Xinhua Pharmaceutical Co Ltd (0719). Check the MyAverix Finance app for the latest dividend data.
What sector is Shandong Xinhua Pharmaceutical Co Ltd in?
Shandong Xinhua Pharmaceutical Co Ltd (0719) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is 0719 listed on?
0719 is listed on HK.
What is Shandong Xinhua Pharmaceutical Co Ltd's net margin?
Shandong Xinhua Pharmaceutical Co Ltd (0719) reports a net margin of 3.0% (data as of 2026-05-21).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.